Mark J. Bamberger
Nessuna posizione attualmente
Profilo
Mark J.
Bamberger worked as the Director of Cardiovascular Disease Research at Pfizer Inc. from 2004 to 2008.
He also served as the Chief Scientific Officer at Stealth BioTherapeutics Corp.
from 2014 to 2020.
Bamberger received his undergraduate degree from St. Joseph's University in 1974 and his doctorate from Drexel University College of Medicine.
Precedenti posizioni note di Mark J. Bamberger
| Società | Posizione | Fine |
|---|---|---|
| STEALTH BIOTHERAPEUTICS CORP | Direttore Tecnico/Scientifico/R&S | 01/01/2020 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2008 |
Formazione di Mark J. Bamberger
| Drexel University College of Medicine | Doctorate Degree |
| St. Joseph's University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Stealth BioTherapeutics Corp.
 Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. The company was founded on April 3, 2006 and is headquartered in Needham, MA. | Health Technology |
- Borsa valori
- Insiders
- Mark J. Bamberger
